ReduX

ReduX

ICO Ended
715 Views
In recent months, much attention has been placed on the energy crisis and climate change. Most technologies today put huge stress on the environment. Even though the existing technological machinery aims to ease life, the impact of their application has a negative impact on the environment. This is where ReduX – the first environmentally conscious technology, comes into the picture. ReduX can be applied practically to any industry, and the benefits offered by this technology are immense. The innovative solutions offered by ReduX can help fight energy shortages and climate change.
5.1
TOTAL SCORE
4.6
ICO PROFILE

(weight: 45%)

1
TEAM PROOF

(weight: 20%)

Get widget
General
Website: Visit
White paper: Read
ICO Time: 01 Dec 2022 - 31 Dec 2022
Token info
Ticker: REDUX
Platform: Binance Chain
Token Type: BEP20
Available for sale: 30,000,000 REDUX (1.5%)
Financial
ICO Price: 0.12 USD
Accepting: BUSD, USDT, USDC
Eduard M. Barcikowski
Founder Chairman Board of Directors
Participates in a number of projects
Peter Mueller
Founder CEO, Board of Directors
Participates in a number of projects
Moritz Zuellig
Founder CFO, Head Advisory Board
Participates in a number of projects

Advisors (0)

HEIGHT - 0px
WIDTH - 0px
PUT THIS CODE TO YOUR WEBSITE
ICO List
Other Interesting ICOs
Active
Rivalz
Rivalz is redefining AI infrastructure by creating an AI Intel Layer to unlock new agentic economies. Built on a dual-chain DePIN architecture using Dymension and Arbitrum, Rivalz addresses one of the biggest bottlenecks in AI today: access to AI-ready, verifiable, and secure data. As we envision the web3 space to become agentic and overtake humans in the amount of transactions over time, what Rivalz is building is key for enabling this future. The core challenge that Rivalz is addressing is the need for AI-ready, verifiable and accessible data and later on intelligence. Rivalz offers a hybrid solution combining decentralized storage and high-speed agent-centric connectivity networks that cater specifically to AI's demands, ushering in the era of the agentic economy.
Upcoming
Apillon
Apillon is a Web3 development platform empowering developers to build in the Polkadot ecosystem. Through standard API connections, it provides the complete technology stack of connected services for creating NFT, GameFi, DeFi, and other Web3 products easily, reliably, and fast.
Upcoming
Fan360
The first sports community for fans, that covers the complete fan experience. Follow your favourite sports star, club or brand and get rewarded for engaging.
Upcoming
Coolomat
Coolomat Market will change the online e-commerce grocery sector with an innovative approach connecting customers and producers, big and small, over a new innovative online platform utilizing blockchain technology and open source software. A big “game changer” is the connection to physical click & collect pick up point devices – Coolomats. Our devices present the first and the only worldwide network of such kind.
Upcoming
Squeezer
Squeezer is a platform that helps software developers build apps easily without tackling the entire blockchain infrastructure. It is also a powerful tool for providing high-quality blockchain software components to large enterprise organizations. Squeezer uses world-class microservices platforms, such as AWS Lambda, Google Functions, and Azure Functions.
Upcoming
Pharmeum
Pharmeum is the world's first blockchain-based prescription platform with AI health analytics, which is currently working alongside the National Health Service (NHS) in England. The Pharmeum platform is an inter-operable, decentralised, digital prescription platform running over an intelligent neural network. Empowering patients’ ownership of their medication history, and enabling affordable access to healthcare globally. Medical errors and late diagnoses are minimised by using a permissioned blockchain integrated with artificial intelligence. Pharmeum is an advanced, digitised, health eco-system.The Pharmeum blockchain will improve medicine affordability, minimise errors, and create frictionless, quality care for patients.